Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21681466 | 0.78 | — | — | |
| SCHEMBL17110502 | 0.77 | L3MBTL1 (0.34) | TUBB1CYP3A4MAPTACHE | |
| SCHEMBL17110488 | 0.77 | CSNK2A1 (0.35) | — | |
| SCHEMBL17110497 | 0.74 | MAPT (0.40) | MAPTPDE4D | |
| SCHEMBL17110548 | 0.71 | MCHR1 (0.32) | — | |
| SCHEMBL6062219 | 0.71 | TRPA1 (0.30) | — | |
| SCHEMBL2233817 | 0.70 | CYP3A4 (0.36) | TUBB1CYP3A4MAPTACHE | |
| SCHEMBL1068238 | 0.70 | CA2 (0.37) | TUBB1MAPTACHE | |
| SCHEMBL20736608 | 0.69 | TUBB1 (0.35) | TUBB1CYP3A4MAPTACHE | |
| SCHEMBL218123 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129358-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | claimed |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | BASF SE (DE) | 2017-02-02 | — | — | US | claimed |
| CN-106164058-A | Diaminourea pyrrolotriazine derivatives as herbicide | 巴斯夫欧洲公司 | 2016-11-23 | — | — | CN | claimed |
| WO-2015155271-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | claimed |
| US-20170101383-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-04-13 | — | — | US | disclosed |
| EP-3129358-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | disclosed |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | BASF SE (DE) | 2017-02-02 | — | — | US | disclosed |
| EP-3122736-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| CN-106164058-A | Diaminourea pyrrolotriazine derivatives as herbicide | 巴斯夫欧洲公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-106132946-A | Diaminourea pyrrolotriazine derivatives as herbicide | 巴斯夫欧洲公司 | 2016-11-16 | — | — | CN | disclosed |
| WO-2015155271-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015155129-A1 | DIAMINOTRIAZINE COMPOUND | BASF SE (DE) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015144881-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101383-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | DRD3, CBR3, ATL3 | TUBB1 1507/4885CYP3A4 2783/4885MAPT 4532/4885 |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | DDT, CBR3, HDHD5 | TUBB1 1618/4885CYP3A4 2656/4885MAPT 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.